On the public citation graph

Primary Membranous Nephropathy

https://doi.org/10.2215/cjn.11761116
0 signed · 777 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/gcc.22440openalex-snapshot
THSD7A expression in human cancer
inferredcites →https://doi.org/10.1002/phar.1575openalex-snapshot
Overview of Current and Alternative Therapies for Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1016/j.autrev.2015.10.004openalex-snapshot
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)
inferredcites →https://doi.org/10.1016/j.ekir.2016.05.002openalex-snapshot
Membranous Nephropathy: Pilot Study of a Novel Regimen Combining Cyclosporine and Rituximab
inferredcites →https://doi.org/10.1016/j.kint.2015.11.032openalex-snapshot
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy
inferredcites →https://doi.org/10.1016/j.kint.2015.12.041openalex-snapshot
Patients with primary membranous nephropathy are at high risk of cardiovascular events
inferredcites →https://doi.org/10.1016/j.kint.2015.12.057openalex-snapshot
Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis
inferredcites →https://doi.org/10.1016/j.kint.2016.02.022openalex-snapshot
Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor–related membranous nephropathy after tacrolimus therapy
inferredcites →https://doi.org/10.1016/j.kint.2016.08.030openalex-snapshot
Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation
inferredcites →https://doi.org/10.1016/j.kint.2016.09.048openalex-snapshot
Membranous nephropathy: integrating basic science into improved clinical management
inferredcites →https://doi.org/10.1016/j.semnephrol.2013.08.004openalex-snapshot
The Role of Complement in Membranous Nephropathy
inferredcites →https://doi.org/10.1016/j.semnephrol.2013.08.009openalex-snapshot
Complement-Mediated Cellular Injury
inferredcites →https://doi.org/10.1016/j.thromres.2012.04.015openalex-snapshot
Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study
inferredcites →https://doi.org/10.1016/s0140-6736(04)17154-7openalex-snapshot
Pathomechanisms and molecular basis of membranous glomerulopathy
inferredcites →https://doi.org/10.1016/s0140-6736(12)61566-9openalex-snapshot
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(15)60731-0openalex-snapshot
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
inferredcites →https://doi.org/10.1038/ki.2010.34openalex-snapshot
Membranous nephropathy: recent travels and new roads ahead
inferredcites →https://doi.org/10.1038/ki.2012.486openalex-snapshot
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
inferredcites →https://doi.org/10.1038/ki.2013.476openalex-snapshot
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy
inferredcites →https://doi.org/10.1038/ki.2013.548openalex-snapshot
Membranous-like glomerulopathy with masked IgG kappa deposits
inferredcites →https://doi.org/10.1038/ki.2014.49openalex-snapshot
The etiology of glomerulonephritis: roles of infection and autoimmunity
inferredcites →https://doi.org/10.1038/kisup.2012.9openalex-snapshot
Shortened red blood cell survival in uremic patients: beneficial and deleterious effects of dialysis.
inferredcites →https://doi.org/10.1038/modpathol.2012.207openalex-snapshot
Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies
inferredcites →https://doi.org/10.1038/modpathol.2016.32openalex-snapshot
THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity
inferredcites →https://doi.org/10.1038/nm.1857openalex-snapshot
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
inferredcites →https://doi.org/10.1038/sj.ki.5001790openalex-snapshot
Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association
inferredcites →https://doi.org/10.1053/j.ajkd.2005.10.016openalex-snapshot
A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1053/j.ajkd.2008.04.013openalex-snapshot
Mycophenolate Mofetil Monotherapy in Membranous Nephropathy: A 1-Year Randomized Controlled Trial
inferredcites →https://doi.org/10.1053/j.ajkd.2013.07.019openalex-snapshot
Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
inferredcites →https://doi.org/10.1053/j.ajkd.2013.12.001openalex-snapshot
Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Glomerulonephritis in Adults
inferredcites →https://doi.org/10.1053/j.ajkd.2015.07.006openalex-snapshot
AJKD Atlas of Renal Pathology: Membranous Nephropathy
inferredcites →https://doi.org/10.1053/j.ajkd.2016.01.030openalex-snapshot
Membranous Nephropathy: A Journey From Bench to Bedside
inferredcites →https://doi.org/10.1056/nejmc1011678openalex-snapshot
PLA 2 R Autoantibodies and PLA 2 R Glomerular Deposits in Membranous Nephropathy
inferredcites →https://doi.org/10.1056/nejmc1511702openalex-snapshot
A Mechanism for Cancer-Associated Membranous Nephropathy
inferredcites →https://doi.org/10.1056/nejmoa012895openalex-snapshot
Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies
inferredcites →https://doi.org/10.1056/nejmoa0810457openalex-snapshot
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1056/nejmoa1009742openalex-snapshot
Risk HLA-DQA1 and PLA 2 R1 Alleles in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1056/nejmoa1409354openalex-snapshot
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1080/17512433.2016.1225497openalex-snapshot
Pharmacological treatment of primary membranous nephropathy in 2016
inferredcites →https://doi.org/10.1093/ckj/sfw045openalex-snapshot
Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1093/ndt/gfq017openalex-snapshot
Alkylating agents in membranous nephropathy: efficacy proven beyond doubt
inferredcites →https://doi.org/10.1093/ndt/gfs439openalex-snapshot
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy
inferredcites →https://doi.org/10.1093/ndt/gfv149.03openalex-snapshot
SaO022EFFECT OF BELIMUMAB ON PROTEINURIA AND ANTI-PLA2R AUTOANTIBODY IN IDIOPATHIC MEMBRANOUS NEPHROPATHY - 6 MONTHS DATA
inferredcites →https://doi.org/10.1093/ndt/gfw404openalex-snapshot
Membranous nephropathy: thinking through the therapeutic options
inferredcites →https://doi.org/10.1093/ndt/gfy049openalex-snapshot
Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model
inferredcites →https://doi.org/10.1097/mnh.0000000000000305openalex-snapshot
Breaking down the complement system
inferredcites →https://doi.org/10.1111/ajt.13133openalex-snapshot
Anti-Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy
inferredcites →https://doi.org/10.1111/cei.12729openalex-snapshot
Immunology of membranous nephropathy: from animal models to humans
inferredcites →https://doi.org/10.1111/ctr.12711openalex-snapshot
Pre‐transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post‐kidney transplantation
inferredcites →https://doi.org/10.1111/ctr.12847openalex-snapshot
Membranous nephropathy in the kidney allograft
inferredcites →https://doi.org/10.1111/eci.12545openalex-snapshot
A new rescue regimen with plasma exchange and rituximab in high‐risk membranous glomerulonephritis
inferredcites →https://doi.org/10.1111/j.1365-2249.1992.tb06459.xopenalex-snapshot
Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli
inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02237.xopenalex-snapshot
Recurrent Idiopathic Membranous Nephropathy After Kidney Transplantation: A Surveillance Biopsy Study
inferredcites →https://doi.org/10.1111/nep.12478openalex-snapshot
Antibodies to m‐type phospholipase A2 receptor in children with idiopathic membranous nephropathy
inferredcites →https://doi.org/10.1111/nep.12569openalex-snapshot
Tacrolimus combined with corticosteroids versus M odified P onticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial
inferredcites →https://doi.org/10.1159/000349976openalex-snapshot
Short-Term Complications of Membranous Nephropathy
inferredcites →https://doi.org/10.1159/000364782openalex-snapshot
Prevalence of Cancer in Membranous Nephropathy: A Systematic Review and Meta-Analysis of Observational Studies
inferredcites →https://doi.org/10.1159/000368589openalex-snapshot
Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?
inferredcites →https://doi.org/10.1159/000448628openalex-snapshot
Venous Thromboembolism in Primary Nephrotic Syndrome - Is the Risk High Enough to Justify Prophylactic Anticoagulation?
inferredcites →https://doi.org/10.1172/jci85265openalex-snapshot
Autoantibodies against thrombospondin type 1 domain–containing 7A induce membranous nephropathy
inferredcites →https://doi.org/10.1186/s12882-017-0459-zopenalex-snapshot
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
inferredcites →https://doi.org/10.1371/journal.pone.0110681openalex-snapshot
PLA2R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System
inferredcites →https://doi.org/10.1371/journal.pone.0142033openalex-snapshot
Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study
inferredcites →https://doi.org/10.1371/journal.pone.0156263openalex-snapshot
Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2009080861openalex-snapshot
Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2012080771openalex-snapshot
Interaction between PLA2R1 and HLA-DQA1 Variants Associates with Anti-PLA2R Antibodies and Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2013020166openalex-snapshot
Genetic Variants in Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2013020185openalex-snapshot
Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy
inferredcites →https://doi.org/10.1681/asn.2013060576openalex-snapshot
Can Genetics Risk-Stratify Patients with Membranous Nephropathy?
inferredcites →https://doi.org/10.1681/asn.2013121315openalex-snapshot
Identification of the Immunodominant Epitope Region in Phospholipase A2 Receptor-Mediating Autoantibody Binding in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2014010091openalex-snapshot
Phospholipase A2 Receptor Antibodies in Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2014050502openalex-snapshot
Identification of a Major Epitope Recognized by PLA2R Autoantibodies in Primary Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2014070640openalex-snapshot
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2014111061openalex-snapshot
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2015010091openalex-snapshot
Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2015101170openalex-snapshot
Immune Response against Autoantigen PLA2R Is not Gambling: Implications for Pathophysiology, Prognosis, and Therapy
inferredcites →https://doi.org/10.1681/asn.2016010050openalex-snapshot
An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain–Containing 7A–Specific Antibodies in Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2016010093openalex-snapshot
Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China
inferredcites →https://doi.org/10.1681/asn.2016020114openalex-snapshot
MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2016040449openalex-snapshot
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
inferredcites →https://doi.org/10.1681/asn.2016060644openalex-snapshot
HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2016070776openalex-snapshot
A Proposal for a Serology-Based Approach to Membranous Nephropathy
inferredcites →https://doi.org/10.2215/cjn.01330209openalex-snapshot
The Natural History of the Non-Nephrotic Membranous Nephropathy Patient
inferredcites →https://doi.org/10.2215/cjn.01910215openalex-snapshot
Drug-Induced Glomerular Disease
inferredcites →https://doi.org/10.2215/cjn.04130414openalex-snapshot
Balancing Cancer Risk and Efficacy of Using Cyclophosphamide to Treat Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.2215/cjn.04160413openalex-snapshot
Glomerular Diseases
inferredcites →https://doi.org/10.2215/cjn.07210810openalex-snapshot
Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.2215/cjn.10471013openalex-snapshot
Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy
inferredcites →https://doi.org/10.2215/cjn.12571213openalex-snapshot
De Novo Glomerular Diseases after Renal Transplantation
inferredcites →https://doi.org/10.3109/1354750x.2014.993708openalex-snapshot
Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens
inferredcites →https://doi.org/10.4049/jimmunol.179.1.172openalex-snapshot
Induction of Passive Heymann Nephritis in Complement Component 6-Deficient PVG Rats

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3739819openalex-extracted
Contactin-1 Antibodies Link Autoimmune Neuropathies to Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1002/2056-4538.70062openalex-snapshot
A membranous nephropathy variant mimicking minimal change disease
inferred← citeshttps://doi.org/10.1002/acr.24738openalex-snapshot
Starting off on the Right Foot: A 22‐Year‐Old Woman With Leg Swelling
inferred← citeshttps://doi.org/10.1002/advs.202404151openalex-snapshot
Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy
inferred← citeshttps://doi.org/10.1002/ame2.70221openalex-snapshot
Animal models of idiopathic membranous nephropathy: Recent advances and future perspectives
inferred← citeshttps://doi.org/10.1002/ccr3.1676openalex-snapshot
Uncommon things to note about a common cause of nephrotic syndrome
inferred← citeshttps://doi.org/10.1002/ccs3.70022openalex-snapshot
Modulation of podocyte extracellular matrix remodeling in membranous nephropathy by the NFATc3/LRRC55/BK channel pathway
inferred← citeshttps://doi.org/10.1002/gch2.201900099openalex-snapshot
Meta‐Analysis of the Diagnostic Efficiency of THSD7A‐AB for the Diagnosis of Idiopathic Membranous Nephropathy
inferred← citeshttps://doi.org/10.1002/jbt.70056openalex-snapshot
Effectiveness of a Novel PLA2R1 Knock‐In Rat Model in Repairing Renal Function Damage
inferred← citeshttps://doi.org/10.1002/jbt.70509openalex-snapshot
Madecassoside Improves Renal Injury via Activation of AMPK/Autophagy in Experimental Membranous Nephropathy
inferred← citeshttps://doi.org/10.1002/jca.21779openalex-snapshot
Successful use of nonantigen‐specific immunoadsorption with antihuman Ig‐columns in kidney graft antibody‐mediated rejection
inferred← citeshttps://doi.org/10.1002/jca.22134openalex-snapshot
Therapeutic plasmapheresis in idiopathic membranous nephropathy anti‐PLA2R‐related: A case series
inferred← citeshttps://doi.org/10.1002/jrs.70085openalex-snapshot
A Multi‐Scale Residual Network Based on Kolmogorov–Arnold Networks Combined With Raman Spectroscopy for Rapid Diagnosis of Membranous Glomerulonephritis
inferred← citeshttps://doi.org/10.1002/mas.70041openalex-snapshot
Advances in Mass Spectrometry‐Based Proteomics for Kidney Disease Biomarker Discovery and Clinical Translation
inferred← citeshttps://doi.org/10.1002/mco2.614openalex-snapshot
Membranous nephropathy: pathogenesis and treatments
inferred← citeshttps://doi.org/10.1002/mco2.760openalex-snapshot
Clinical glycoproteomics: methods and diseases
inferred← citeshttps://doi.org/10.1002/prot.25640openalex-snapshot
Structure and function insights garnered from in silico modeling of the thrombospondin type‐1 domain‐containing 7A antigen
inferred← citeshttps://doi.org/10.1007/978-3-030-44858-5_24openalex-snapshot
Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-030-76419-7_18openalex-snapshot
Management of the Nephrotic Patient: The Overall Approach to the Patient with Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-031-68460-9_10openalex-snapshot
Glomerular Disease in the Elderly
inferred← citeshttps://doi.org/10.1007/978-3-031-97297-3_25openalex-snapshot
Development of Animal Models for Preclinical Testing of hPSCs Products
inferred← citeshttps://doi.org/10.1007/978-981-16-7897-4_4openalex-snapshot
Therapeutic Protein Against Autoimmune Disorders: Intracellular and Extracellular Properties
inferred← citeshttps://doi.org/10.1007/978-981-19-1430-0_4openalex-snapshot
Membranous Glomerulopathy (MGN)
inferred← citeshttps://doi.org/10.1007/978-981-97-0511-5_8openalex-snapshot
Expression and Clinical Significance of Non B Cell-Derived Immunoglobulins in the Urinary System and Male Reproductive System
inferred← citeshttps://doi.org/10.1007/s00108-019-0573-zopenalex-snapshot
Membranöse Glomerulonephritis
inferred← citeshttps://doi.org/10.1007/s00277-024-05875-wopenalex-snapshot
Clinical characteristics of membranous nephropathy after allogeneic hematopoietic stem cell transplantation: A real-world multicenter study
inferred← citeshttps://doi.org/10.1007/s00292-022-01061-9openalex-snapshot
Grundlagen der Nierenpathologie für Pathologen – Teil 1
inferred← citeshttps://doi.org/10.1007/s00428-019-02558-0openalex-snapshot
Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s00428-024-03921-6openalex-snapshot
Clinicopathological characteristics of neural epidermal growth factor-like 1 protein-associated membranous glomerulonephritis
inferred← citeshttps://doi.org/10.1007/s00467-019-04425-1openalex-snapshot
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era
inferred← citeshttps://doi.org/10.1007/s00467-020-04867-yopenalex-snapshot
Biomarkers in pediatric glomerulonephritis and nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-022-05503-7openalex-snapshot
Clinicopathologic features of non-lupus membranous nephropathy in a pediatric population
inferred← citeshttps://doi.org/10.1007/s00467-026-07432-1openalex-snapshot
Risk stratification guided treatment and outcomes of pediatric membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s10072-022-06215-4openalex-snapshot
Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy
inferred← citeshttps://doi.org/10.1007/s10157-020-02011-6openalex-snapshot
Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s10157-021-02147-zopenalex-snapshot
Evaluation of ultrastructural alterations of glomerular basement membrane and podocytes in glomeruli by low-vacuum scanning electron microscopy
inferred← citeshttps://doi.org/10.1007/s10157-023-02444-9openalex-snapshot
Urine albumin-to-creatinine ratio diurnal variation rate predicts outcomes in idiopathic membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s10157-024-02566-8openalex-snapshot
Causality between diabetes and membranous nephropathy: Mendelian randomization
inferred← citeshttps://doi.org/10.1007/s10157-025-02731-7openalex-snapshot
Clinical outcomes of immunosuppressive therapy in patients with seronegative anti-PLA2R antibodies and PLA2R-related membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s10895-022-02888-4openalex-snapshot
Establishment of Galectin-3 Time-resolved Fluoroimmunoassay and its Application in Idiopathic Membranous Nephropathy
inferred← citeshttps://doi.org/10.1007/s10904-024-03516-3openalex-snapshot
A Synergistic Semaglutide-targeted Fluorescent Nanodrug Delivery System and its Therapeutic Efficacy in Diabetic Nephropathy Treatment
inferred← citeshttps://doi.org/10.1007/s11010-022-04650-7openalex-snapshot
APC ameliorates idiopathic membranous nephropathy by affecting podocyte apoptosis through the ERK1/2/YB-1/PLA2R1 axis
inferred← citeshttps://doi.org/10.1007/s11042-024-18536-xopenalex-snapshot
Classification and quantification of glomerular spike-like projections via deep residual multiple instance learning with multi-scale annotation
inferred← citeshttps://doi.org/10.1007/s11255-020-02633-5openalex-snapshot
Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis
inferred← citeshttps://doi.org/10.1007/s11255-020-02698-2openalex-snapshot
The correlation of anti-β2-glycoprotein I antibody with complement activation in patients with idiopathic membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s11255-021-02859-xopenalex-snapshot
Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s11255-021-02881-zopenalex-snapshot
Epidemiology of biopsy-proven glomerulonephritis in the past 25 years in the North-Eastern area of Romania
inferred← citeshttps://doi.org/10.1007/s11255-021-02997-2openalex-snapshot
Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy
inferred← citeshttps://doi.org/10.1007/s11255-022-03372-5openalex-snapshot
Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1007/s11255-023-03523-2openalex-snapshot
Clinicopathological characteristics and associated factors of idiopathic membranous nephropathy with hyperuricemia: a single-centered cross-sectional study
inferred← citeshttps://doi.org/10.1007/s11255-023-03682-2openalex-snapshot
Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria
inferred← citeshttps://doi.org/10.1007/s11255-023-03803-xopenalex-snapshot
Prognostic value of neutrophil-to-lymphocyte ratio on proteinuria remission in patients with idiopathic membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s11255-025-04407-3openalex-snapshot
Observation of the efficacy and safety of obinutuzumab in the treatment of refractory idiopathic membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s11255-025-04557-4openalex-snapshot
Finerenone’s safety and efficacy in membranous nephropathy: an emerging perspective
inferred← citeshttps://doi.org/10.1007/s11255-026-05123-2openalex-snapshot
MiR-423-5p inhibition alleviates podocyte apoptosis in membranous nephropathy by targeting WT1/β-catenin axis
inferred← citeshttps://doi.org/10.1007/s11255-026-05301-2openalex-snapshot
Association between anti-PLA2R antibody status and clinical remission in primary membranous nephropathy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s11427-023-2305-0openalex-snapshot
Biomarkers of aging
inferred← citeshttps://doi.org/10.1007/s11560-017-0184-4openalex-snapshot
Membranöse Glomerulonephritis
inferred← citeshttps://doi.org/10.1007/s11560-020-00467-xopenalex-snapshot
Nephrotisches Syndrom bei einer Schwangeren in der 9. SSW
inferred← citeshttps://doi.org/10.1007/s11560-024-00806-2openalex-snapshot
Membranöse Glomerulonephritis
inferred← citeshttps://doi.org/10.1007/s12033-023-00934-5openalex-snapshot
THSD7A as a Promising Biomarker for Membranous Nephrosis
inferred← citeshttps://doi.org/10.1007/s12539-021-00466-zopenalex-snapshot
Biomarker Identification in Membranous Nephropathy Using a Long Non-coding RNA-Mediated Competitive Endogenous RNA Network
inferred← citeshttps://doi.org/10.1007/s13730-020-00524-3openalex-snapshot
COVİD-19 infection in a membranous nephropathy patient treated with rituximab
inferred← citeshttps://doi.org/10.1007/s13730-020-00560-zopenalex-snapshot
Fecal microbiota transplantation for membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s13730-021-00641-7openalex-snapshot
Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report
inferred← citeshttps://doi.org/10.1007/s13730-024-00941-8openalex-snapshot
A case of PLA2R-positive membranous nephropathy with subsequent development of IgG4-related disease
inferred← citeshttps://doi.org/10.1007/s13730-026-01116-3openalex-snapshot
Membranous nephropathy secondary to very early-onset inflammatory bowel disease in a 3-year-old boy: case report
inferred← citeshttps://doi.org/10.1007/s40265-021-01656-1openalex-snapshot
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
inferred← citeshttps://doi.org/10.1007/s40477-026-01159-3openalex-snapshot
A machine learning model integrating two-dimensional ultrasound radiomics and clinical parameters for differentiating membranous nephropathy from IgA nephropathy
inferred← citeshttps://doi.org/10.1007/s40620-017-0451-5openalex-snapshot
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases
inferred← citeshttps://doi.org/10.1007/s40620-020-00816-yopenalex-snapshot
Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases
inferred← citeshttps://doi.org/10.1007/s40620-020-00874-2openalex-snapshot
Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab
inferred← citeshttps://doi.org/10.1007/s40620-020-00888-wopenalex-snapshot
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
inferred← citeshttps://doi.org/10.1007/s40620-022-01493-9openalex-snapshot
From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
inferred← citeshttps://doi.org/10.1007/s40620-023-01779-6openalex-snapshot
Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy
inferred← citeshttps://doi.org/10.1007/s40620-023-01821-7openalex-snapshot
A membranous nephropathy in a 5 year-old boy: and if that’s not all? A nephrology quiz
inferred← citeshttps://doi.org/10.1007/s40620-024-01893-zopenalex-snapshot
Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy
inferred← citeshttps://doi.org/10.1016/b978-0-12-815389-5.00051-4openalex-snapshot
Glomerular disorders
inferred← citeshttps://doi.org/10.1016/b978-0-12-815876-0.00045-0openalex-snapshot
Approach to the Patient with Chronic Glomerular Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-815876-0.00051-6openalex-snapshot
Approach to Chronic Kidney Disease in the Diabetic Patient
inferred← citeshttps://doi.org/10.1016/b978-0-323-66165-2.00010-7openalex-snapshot
Ureter, Urinary Bladder, and Kidney
inferred← citeshttps://doi.org/10.1016/b978-0-323-85389-7.00011-9openalex-snapshot
Membranous nephropathy: Clinical and immunological aspects
inferred← citeshttps://doi.org/10.1016/b978-0-323-99130-8.00014-3openalex-snapshot
Renal Autoimmunity: The Role of Bacterial and Viral Infections – An Extensive Review
inferred← citeshttps://doi.org/10.1016/b978-0-443-19200-5.00009-9openalex-snapshot
Anti-CD20 antibodies in glomerular diseases, their resistance and reversal approaches
inferred← citeshttps://doi.org/10.1016/b978-0-443-23947-2.00076-xopenalex-snapshot
Autoimmune diseases of the kidney
inferred← citeshttps://doi.org/10.1016/b978-2-294-76353-3.00035-2openalex-snapshot
Glomérulonéphrites extramembraneuses
inferred← citeshttps://doi.org/10.1016/b978-3-437-21335-9.00037-3openalex-snapshot
20 Jahre Glomerulonephritis
inferred← citeshttps://doi.org/10.1016/b978-3-437-21691-6.00003-7openalex-snapshot
Glomerulonephritiden und Vaskulitiden
inferred← citeshttps://doi.org/10.1016/j.amjms.2021.09.008openalex-snapshot
Immunosuppressive Treatments for Idiopathic Membranous Nephropathy: A Pilot Study According to Histopathological Stages
inferred← citeshttps://doi.org/10.1016/j.autrev.2021.102976openalex-snapshot
Course monitoring of membranous nephropathy: Both autoantibodies and podocytes require multidimensional attention
inferred← citeshttps://doi.org/10.1016/j.autrev.2022.103073openalex-snapshot
Renal autoimmunity: The role of bacterial and viral infections, an extensive review
inferred← citeshttps://doi.org/10.1016/j.autrev.2025.103763openalex-snapshot
Complement-coagulation crosstalk in idiopathic membranous nephropathy: The potential pathogenesis and therapeutic perspective
inferred← citeshttps://doi.org/10.1016/j.bbrep.2021.101102openalex-snapshot
Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112349openalex-snapshot
Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112475openalex-snapshot
Structural modulation of gut microbiota during alleviation of experimental passive Heymann nephritis in rats by a traditional Chinese herbal formula
inferred← citeshttps://doi.org/10.1016/j.bspc.2022.104562openalex-snapshot
Generative adversarial feature learning for glomerulopathy histological classification
inferred← citeshttps://doi.org/10.1016/j.cca.2018.06.050openalex-snapshot
Clinical and prognostic significance of glomerular C1q deposits in primary MN
inferred← citeshttps://doi.org/10.1016/j.cca.2019.11.004openalex-snapshot
Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease
inferred← citeshttps://doi.org/10.1016/j.cca.2025.120142openalex-snapshot
Development of a time-resolved fluoroimmunoassay for rituximab and its application to therapeutic drug monitoring
inferred← citeshttps://doi.org/10.1016/j.cca.2026.120882openalex-snapshot
Development of machine learning-driven non-invasive diagnostic models for idiopathic membranous nephropathy in Chinese patients
inferred← citeshttps://doi.org/10.1016/j.cca.2026.121249openalex-snapshot
Diagnostic pitfall: NSAID-induced membranous nephropathy with PLA2R positivity, IgG1-predominant deposits, C1q positivity, and concurrent acute interstitial nephritis—A case report
inferred← citeshttps://doi.org/10.1016/j.clim.2022.108976openalex-snapshot
Revisiting immunological and clinical aspects of membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.cmpb.2022.107106openalex-snapshot
IDA-MIL: Classification of Glomerular with Spike-like Projections via Multiple Instance Learning with Instance-level Data Augmentation
inferred← citeshttps://doi.org/10.1016/j.cyto.2021.155452openalex-snapshot
Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2025.118280openalex-snapshot
Fine particulate matter (PM2.5) induces microRNA-192–5p causing glomerular damage
inferred← citeshttps://doi.org/10.1016/j.ekir.2019.09.005openalex-snapshot
Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)
inferred← citeshttps://doi.org/10.1016/j.ekir.2019.11.008openalex-snapshot
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2019.12.006openalex-snapshot
Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.01.010openalex-snapshot
Membranous Nephropathy With Crescents
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.01.018openalex-snapshot
Proteomic Analysis of Complement Proteins in Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.06.024openalex-snapshot
Profile of Indian Patients With Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.12.034openalex-snapshot
A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.12.035openalex-snapshot
Rituximab in Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2021.02.025openalex-snapshot
Identification of a Locus on the X Chromosome Linked to Familial Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2021.06.010openalex-snapshot
Repository Corticotropin Injections Promote Clinical Remission and Regulatory T Cell Expansion in Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2022.10.008openalex-snapshot
C5b-9 Glomerular Deposits Are Associated With Poor Renal Survival in Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.03.016openalex-snapshot
COVID-19 and Glomerular Diseases
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.08.018openalex-snapshot
Clinical and Histopathologic Characteristics of Pediatric Patients With Primary Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.10.023openalex-snapshot
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence
inferred← citeshttps://doi.org/10.1016/j.ekir.2024.09.016openalex-snapshot
Pilot Trial of Hydroxychloroquine as Add-On Therapy in Patients With Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2024.09.024openalex-snapshot
Case Studies of Sustained Remission of Membranous Glomerulonephritis With Dupilumab Treatment
inferred← citeshttps://doi.org/10.1016/j.ekir.2025.03.027openalex-snapshot
Risk Factors for Disease Progression for Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)
inferred← citeshttps://doi.org/10.1016/j.ekir.2025.05.034openalex-snapshot
Lipidomics Unveils Critical Lipid Pathway Shifts in Alport Syndrome
inferred← citeshttps://doi.org/10.1016/j.ekir.2025.11.020openalex-snapshot
Circulating Testican-2 and MGT5A are Markers of Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2026.106582openalex-snapshot
Optimization of a Target Antigen Diagnostic Pathway for Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2026.107014openalex-snapshot
Single-Nucleus Transcriptomic Atlas Reveals Disease-Associated Cellular States in Human Glomerular Diseases
inferred← citeshttps://doi.org/10.1016/j.exger.2023.112341openalex-snapshot
Experimental models for elderly patients with membranous nephropathy: Application and advancements
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e28836openalex-snapshot
Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e38424openalex-snapshot
Integrated bioinformatics analysis for identifying fibroblast-associated biomarkers and molecular subtypes in human membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.03.002openalex-snapshot
Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107376openalex-snapshot
Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.108635openalex-snapshot
Novel treatment options in rituximab-resistant membranous nephropathy patients
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109412openalex-snapshot
Cytokines network in primary membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.110317openalex-snapshot
Membranous nephropathy: Mechanistic insights and therapeutic perspectives
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.111126openalex-snapshot
Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112731openalex-snapshot
Low risk of hepatitis B virus reactivation in membranous nephropathy patients with resolved infection undergoing rituximab-based regimens without antiviral prophylaxis
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112769openalex-snapshot
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113379openalex-snapshot
The outcomes of primary membranous nephropathy treated with cyclophosphamide are superior to calcineurin inhibitors in patients with renal vascular lesions: A multi-center retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jaut.2023.103109openalex-snapshot
Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.101605openalex-snapshot
Structural determinants of the dominant conformational epitopes of phospholipase A2 receptor in primary membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.jep.2024.118233openalex-snapshot
Oral bacteriome and mycobiome of patients with idiopathic membranous nephropathy with different tongue coatings treated with a Chinese herbal formula
inferred← citeshttps://doi.org/10.1016/j.jfma.2021.06.014openalex-snapshot
Advances in antigens associated with Idiopathic Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2024.578460openalex-snapshot
Characteristics of anti-contactin1 antibody positive autoimmune nodopathies combined with membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2024.578472openalex-snapshot
Kidney injury: An overlooked manifestation in autoimmune encephalitis
inferred← citeshttps://doi.org/10.1016/j.jprot.2023.105064openalex-snapshot
A comparative urinary proteomic and metabolomic analysis between renal aa amyloidosis and membranous nephropathy with clinicopathologic correlations
inferred← citeshttps://doi.org/10.1016/j.jprot.2024.105223openalex-snapshot
Deep analysis of total serum N-glycome suggests glyco-signatures for phospholipase A2 receptor 1-related idiopathic membranous nephropathy diagnosis
inferred← citeshttps://doi.org/10.1016/j.jtauto.2024.100263openalex-snapshot
IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
inferred← citeshttps://doi.org/10.1016/j.jvsv.2023.03.019openalex-snapshot
Comparative outcomes of anticoagulation alone versus anticoagulation plus endovascular intervention in adults with isolated renal vein thrombosis
inferred← citeshttps://doi.org/10.1016/j.kint.2018.10.021openalex-snapshot
Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies
inferred← citeshttps://doi.org/10.1016/j.kint.2019.04.018openalex-snapshot
ACTH (corticotrophin) therapy in resistant primary membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2019.09.014openalex-snapshot
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2020.01.037openalex-snapshot
The pathogenesis of human membranous nephropathy: we are (almost) there
inferred← citeshttps://doi.org/10.1016/j.kint.2020.05.030openalex-snapshot
Semaphorin 3B–associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients
inferred← citeshttps://doi.org/10.1016/j.kint.2020.06.014openalex-snapshot
The clinicopathologic spectrum of segmental membranous glomerulopathy
inferred← citeshttps://doi.org/10.1016/j.kint.2020.06.031openalex-snapshot
Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2020.10.014openalex-snapshot
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2021.03.028openalex-snapshot
A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2021.08.014openalex-snapshot
Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2023.06.032openalex-snapshot
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
inferred← citeshttps://doi.org/10.1016/j.kint.2024.01.017openalex-snapshot
A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.kint.2026.05.017openalex-snapshot
Quantitative serological detection of NELL1 autoantibodies in membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.kintcr.2026.100074openalex-snapshot
Successful Use of Obinutuzumab in Refractory Phospholipase A2 Receptor–Associated Membranous Nephropathy: A Case Report
inferred← citeshttps://doi.org/10.1016/j.lfs.2019.116923openalex-snapshot
Immune system-mediated cellular and molecular mechanisms in idiopathic membranous nephropathy pathogenesis and possible therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119463openalex-snapshot
Roles of microRNAs in renal disorders related to primary podocyte dysfunction
inferred← citeshttps://doi.org/10.1016/j.mayocp.2021.01.011openalex-snapshot
Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.mayocp.2023.08.006openalex-snapshot
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
inferred← citeshttps://doi.org/10.1016/j.mcp.2023.101914openalex-snapshot
Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.medcle.2021.02.004openalex-snapshot
Primary membranous nephropathy in the era of autoantibodies and biological therapies
inferred← citeshttps://doi.org/10.1016/j.medcle.2022.10.021openalex-snapshot
Clinical characteristics of membranous nephropathy with spontaneous remission: An analysis of 24 patients
inferred← citeshttps://doi.org/10.1016/j.medcli.2021.02.010openalex-snapshot
Nefropatía membranosa primaria en la era de los autoanticuerpos y de las terapias biológicas
inferred← citeshttps://doi.org/10.1016/j.medcli.2022.10.014openalex-snapshot
Clinical characteristics of membranous nephropathy with spontaneous remission: An analysis of 24 patients
inferred← citeshttps://doi.org/10.1016/j.molimm.2020.10.015openalex-snapshot
Complement-mediated kidney diseases
inferred← citeshttps://doi.org/10.1016/j.nefro.2026.501529openalex-snapshot
Clinical phenotype predicts anti-PLA2R serology in nephrotic range proteinuria
inferred← citeshttps://doi.org/10.1016/j.pdpdt.2024.104230openalex-snapshot
Evaluation of retinal microcirculation by optical coherence tomography angiography in patients with primary membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.phymed.2023.155196openalex-snapshot
Pharmacological potential of Astragali Radix for the treatment of kidney diseases
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.157467openalex-snapshot
Managing circadian rhythm involved in alleviating membranous nephropathy by alkaloids of Alstonia scholaris
inferred← citeshttps://doi.org/10.1016/j.pop.2020.08.002openalex-snapshot
Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1016/j.rcreu.2024.03.003openalex-snapshot
Primary membranous nephropathy in Latin America: A multicentre study
inferred← citeshttps://doi.org/10.1016/j.rcreue.2025.06.004openalex-snapshot
Primary membranous nephropathy in Latin America: A multicentre study
inferred← citeshttps://doi.org/10.1016/j.semnephrol.2022.01.005openalex-snapshot
Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach
inferred← citeshttps://doi.org/10.1016/j.smim.2019.101331openalex-snapshot
Complement dysregulation in glomerulonephritis
inferred← citeshttps://doi.org/10.1016/j.transproceed.2018.03.083openalex-snapshot
Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report
inferred← citeshttps://doi.org/10.1016/j.transproceed.2021.11.041openalex-snapshot
De Novo Membranous Nephropathy Associated With Antibody-Mediated Rejection in Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1016/j.xkme.2020.07.008openalex-snapshot
Functional Magnetic Resonance Imaging Versus Kidney Biopsy to Assess Response to Therapy in Nephrotic Syndrome: A Case Report
inferred← citeshttps://doi.org/10.1016/j.ygeno.2024.110796openalex-snapshot
Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment
inferred← citeshttps://doi.org/10.1016/s1773-035x(22)00177-0openalex-snapshot
Auto-anticorps dans les glomérulonéphrites extra-membraneuses, marqueurs présents et futurs
inferred← citeshttps://doi.org/10.1021/acsptsci.4c00495openalex-snapshot
Melatonin Alleviates Albumin-Induced Tubular Cell Injury by Activating Clock-Controlled Nuclear Enriched Abundant Transcript 1-Mediated Proliferation
inferred← citeshttps://doi.org/10.1024/1661-8157/a003223openalex-snapshot
CME: Das nephrotische Syndrom beim Erwachsenen: Präsentation, Abklärung, Therapie
inferred← citeshttps://doi.org/10.1038/s41401-022-00978-4openalex-snapshot
Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms
inferred← citeshttps://doi.org/10.1038/s41467-019-09329-0openalex-snapshot
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
inferred← citeshttps://doi.org/10.1038/s41572-021-00303-zopenalex-snapshot
Membranous nephropathy
inferred← citeshttps://doi.org/10.1038/s41572-021-00310-0openalex-snapshot
Membranous Nephropathy
inferred← citeshttps://doi.org/10.1038/s41581-019-0185-9openalex-snapshot
Immunology of the ageing kidney
inferred← citeshttps://doi.org/10.1038/s41581-020-0329-yopenalex-snapshot
Complexities of the glomerular basement membrane
inferred← citeshttps://doi.org/10.1038/s41581-022-00564-1openalex-snapshot
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
inferred← citeshttps://doi.org/10.1038/s41581-025-00980-zopenalex-snapshot
Antigens in membranous nephropathy: discovery and clinical implications
inferred← citeshttps://doi.org/10.1038/s41598-020-67910-wopenalex-snapshot
Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases
inferred← citeshttps://doi.org/10.1038/s41598-021-04274-9openalex-snapshot
Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly
inferred← citeshttps://doi.org/10.1038/s41598-021-88343-zopenalex-snapshot
Rapid, quantitative, and high-sensitivity detection of anti-phospholipase A2 receptor antibodies using a novel CdSe/ZnS-based fluorescence immunosorbent assay
inferred← citeshttps://doi.org/10.1038/s41598-023-33377-8openalex-snapshot
Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients
showing the first 200 of 686
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.